S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
Log in

Thermo Fisher Scientific Stock Price, Forecast & Analysis (NYSE:TMO)

$306.42
+5.43 (+1.80 %)
(As of 11/19/2019 04:00 PM ET)
Today's Range
$301.58
Now: $306.42
$307.02
50-Day Range
$274.18
MA: $292.37
$306.81
52-Week Range
$208.34
Now: $306.42
$307.02
Volume1.05 million shs
Average Volume1.55 million shs
Market Capitalization$122.87 billion
P/E Ratio27.56
Dividend Yield0.25%
Beta1.14
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Read More…

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
CUSIP88355610
Phone781-622-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.36 billion
Cash Flow$16.82 per share
Book Value$68.52 per share

Profitability

Net Income$2.94 billion

Miscellaneous

Employees70,000
Market Cap$122.87 billion
Next Earnings Date1/29/2020 (Estimated)
OptionableOptionable

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.


Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Friday, November 8th. Stockholders of record on Tuesday, December 17th will be given a dividend of $0.19 per share on Wednesday, January 15th. This represents a $0.76 annualized dividend and a dividend yield of 0.25%. The ex-dividend date of this dividend is Monday, December 16th. View Thermo Fisher Scientific's Dividend History.

How will Thermo Fisher Scientific's stock buyback program work?

Thermo Fisher Scientific declared that its Board of Directors has authorized a share repurchase plan on Friday, November 8th 2019, which permits the company to repurchase $2,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its shares are undervalued.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) posted its quarterly earnings data on Wednesday, October, 23rd. The medical research company reported $2.94 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.88 by $0.06. The medical research company earned $6.27 billion during the quarter, compared to analysts' expectations of $6.19 billion. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.16%. The company's revenue for the quarter was up 5.9% on a year-over-year basis. During the same period last year, the company earned $2.62 earnings per share. View Thermo Fisher Scientific's Earnings History.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Thermo Fisher Scientific.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific issued an update on its FY19 earnings guidance on Wednesday, October, 23rd. The company provided earnings per share guidance of $12.28-12.34 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.26. The company issued revenue guidance of $25.34-25.5 billion, compared to the consensus revenue estimate of $25.42 billion.

What price target have analysts set for TMO?

13 Wall Street analysts have issued 12 month price objectives for Thermo Fisher Scientific's shares. Their forecasts range from $300.00 to $345.00. On average, they expect Thermo Fisher Scientific's stock price to reach $318.64 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View Analyst Price Targets for Thermo Fisher Scientific.

What is the consensus analysts' recommendation for Thermo Fisher Scientific?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Thermo Fisher Scientific.

Has Thermo Fisher Scientific been receiving favorable news coverage?

Media stories about TMO stock have been trending very negative on Tuesday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Thermo Fisher Scientific earned a media sentiment score of -3.4 on InfoTrie's scale. They also gave news headlines about the medical research company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Thermo Fisher Scientific.

Are investors shorting Thermo Fisher Scientific?

Thermo Fisher Scientific saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 3,930,000 shares, an increase of 16.3% from the September 15th total of 3,380,000 shares. Based on an average daily volume of 1,520,000 shares, the days-to-cover ratio is currently 2.6 days. Approximately 1.0% of the shares of the stock are short sold. View Thermo Fisher Scientific's Current Options Chain.

Who are some of Thermo Fisher Scientific's key competitors?

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Thermo Fisher Scientific investors own include Home Depot (HD), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Cisco Systems (CSCO), Honeywell International (HON), Walt Disney (DIS), Amgen (AMGN), Visa (V) and NVIDIA (NVDA).

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 51)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 52)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 56)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 53)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 52)

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (4.21%), Veritas Asset Management LLP (0.67%), C WorldWide Group Holding A S (0.51%), Sumitomo Mitsui Trust Holdings Inc. (0.42%), CIBC Private Wealth Group LLC (0.26%) and Cantillon Capital Management LLC (0.25%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Stephen Williamson, Tyler Jacks and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Which institutional investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Columbus Circle Investors, C WorldWide Group Holding A S, Waratah Capital Advisors Ltd., Polaris Greystone Financial Group LLC, Mackay Shields LLC, Veritas Asset Management LLP and Alta Capital Management LLC. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include C Martin Harris, Gregory J Herrema, Jim P Manzi, Marc N Casper, Peter E Hornstra, Stephen Williamson and Tyler Jacks. View Insider Buying and Selling for Thermo Fisher Scientific.

Which institutional investors are buying Thermo Fisher Scientific stock?

TMO stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, State of New Jersey Common Pension Fund D, SG Americas Securities LLC, Bartlett & Co. LLC, Virginia Retirement Systems ET AL, Great West Life Assurance Co. Can, Assenagon Asset Management S.A. and State of Tennessee Treasury Department. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $306.42.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $122.87 billion and generates $24.36 billion in revenue each year. The medical research company earns $2.94 billion in net income (profit) each year or $11.12 on an earnings per share basis. Thermo Fisher Scientific employs 70,000 workers across the globe.View Additional Information About Thermo Fisher Scientific.

What is Thermo Fisher Scientific's official website?

The official website for Thermo Fisher Scientific is http://www.thermofisher.com/.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]


MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  829 (Vote Outperform)
Underperform Votes:  333 (Vote Underperform)
Total Votes:  1,162
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe TMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel